Week High

 
News Articles for Week High top ^
By Benjamin Pimentel, MarketWatch Apple Inc. shares hit a 52-week high Friday as the company geared up for its big developer conference and speculation built it was near to disclosing a deal for Beats Electronics LLC.
Sign-up for Apple hits 52-week high as Beats buzz builds investment picks
SAN FRANCISCO (MarketWatch) -- Apple Inc. (AAPL) shares briefly reached a 52-week-high of $595.98 before pulling back in early trading Tuesday.
Sign-up for Apple rises to 52-week high before retreating investment picks
2014/4/17
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Barclays PLC helped push U.K. stocks higher on Thursday after the bank said it will outline a growth strategy, aiding the main London index to finish at its highest close in a week.
Sign-up for UPDATE: U.K. stocks rise to one-week high; Barclays jumps investment picks
2014/4/17
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Barclays PLC led U.K. stocks higher on Thursday after the bank outlined a new growth strategy, helping to keep the main London index on track for the highest close in a week.
Sign-up for UPDATE: U.K. stocks flirt with one-week high; Barclays rise investment picks
2014/4/24
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 index closed at its highest level in almost seven weeks on Thursday, with Smith & Nephew and AstraZeneca leading stocks higher after well-received corporate news.
Sign-up for UPDATE: AstraZeneca, Smith & Nephew push FTSE to 7-week high investment picks
2014/4/24
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 index headed for its highest close in almost seven weeks on Thursday, with Anglo American and AstraZeneca leading stocks higher after well-received trading updates.
Sign-up for AstraZeneca, Anglo American push FTSE to 7-week high investment picks
2014/4/22
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. equities advanced Tuesday, with AstraZeneca PLC gaining on speculation the British drug maker will receive a takeover bid, while GlaxoSmithKline PLC shares rose as the pharmaceutical heavyweight made a couple of its own deals.
Sign-up for UPDATE: Glaxo, AstraZeneca lead U.K. stocks to two-week high investment picks
2014/4/21
By Myra P.
Sign-up for UPDATE: Oil prices edge up to settle at 7-week high investment picks
2014/4/24
By Myra P.
Sign-up for UPDATE: Gold ends at one-week high on safe-haven demand investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Week High
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Wealth Management Companies  |  Next: Weekly Gains